Immunological mechanisms of vaccine-induced protection against COVID-19 in humans

Cited by (513)

Items 401–500 of 513

1. Role of vaccination and anti-SARS-CoV-2 antibodies in the clinical outcome of hospitalized COVID-19 patients
   Enrique Bernal, Eva García-Villalba, Eduardo Pons, María Rosario Vicente, Cristina Tomás, Alfredo Minguela, Maria Dolores Hernández, Gabriel Puche, Paula Carter, Mónica Martínez Martínez et al. · 2023 · Medicina Clínica
2. Safety of COVID-19 vaccines in pregnancy: a Canadian National Vaccine Safety (CANVAS) Network study
   2022
3. Homologous and heterologous booster of COVID-19 vaccines: A systematic review and meta-analysis
   Rejwana Haque Pial, Sumyta Rahman, Iffat Nowrin, Md Zamiur Rahaman, Sushant Sahastrabuddhe, Hee Soo Kim, Tarun Saluja, KM Saif‐Ur‐Rahman · 2025 · New Microbes and New Infections
4. Determinants of success and failure of antibody-based strategies against respiratory viruses: insights from RSV and SARS-CoV-2
   2026
5. Minimal Change Nephrotic Syndrome with Acute Kidney Injury after the Administration of Pfizer-BioNTech COVID-19 Vaccine
   Erdinç Gülümsek, Dilan Damla Öztürk, Hüseyin Ali Öztürk · 2023 · Case Reports in Infectious Diseases
6. Impact of mRNA COVID-19 vaccination on hematological parameters in patients maintained on clozapine: A retrospective study from Qatar
   Dalia Albahari, Oraib Abdallah, Shatha Mahmud Ismail Alqam, Mohammed Faisal Hamad Mohammed, Mohamed Ali Ahmed, Ovais Wadoo · 2025 · Exploratory Research in Clinical and Social Pharmacy
7. T-Cell Epitope-Based SARS-CoV-2 DNA Vaccine Encoding an Antigen Fused with Type 1 Herpes Simplex Virus Glycoprotein D (gD)
   2025
8. Modeling the Spread of COVID-19 with the Control of Mixed Vaccine Types during the Pandemic in Thailand
   Tanatorn Intarapanya, Apichat Suratanee, Sittiporn Pattaradilokrat · 2023 · Tropical Medicine and Infectious Disease
9. Exposure to SARS-CoV-2 Spike protein during development induces astrogliosis, synapse loss and long-term cognitive dysfunction in mice
   Débora Magalhães Portela, Bruna Andrade, Emanuelle Vasconcellos de Lima, Vitor Gayger-Dias, Daniel Fernandes Messor, Larissa Daniele Bobermin, Lidia Paúra, Marcos Romário Matos de Souza, Sanclayver Corrêa Araújo, Isadora Alonso Corrêa et al. · 2026 · Brain Behavior and Immunity
10. Comparable efficacy and safety of COVID-19 vaccines for patients receiving tegafur–uracil as postoperative adjuvant chemotherapy
    Megumi Nishikubo, Yugo Tanaka, Suguru Mitsui, Takefumi Doi, Daisuke Hokka, Wataru Hojo, Hironori Sakai, Yohei Funakoshi, Kimikazu Yakushijin, Goh Ohji et al. · 2023 · Surgery Today
11. COMPARATIVE EFFECTIVENESS OF mRNA, INACTIVATED, AND VIRAL-VECTOR VACCINES IN PREVENTING INFECTIOUS DISEASES
    2025
12. The vaccine platform used for COVID-19 primary immunization shapes the quality of the human B cell response to a vaccine boost
    Noemia S. Lima, Lauren McCormick, Samuel Li, Christian Wake, Rahul Subramanian, Abby Spangler, Yoav Pinto, William L Catalano, Amy R. Henry, Farida Laboune et al. · 2026 · Science Translational Medicine
13. Assessing the long-stand antibody response induced by COVID-19 vaccines: A study in an educational cohort in San Luis, Argentina
    R. J. Eliçabe, Matías Nicolás Distel, B. Jofré, Marianela Leporati, J. E. Silva, J. Arias, C. Gorlino, S. Funes, Marisol Velazquez, Patricia Vitale et al. · 2022 · Vaccine
14. Competition between T Cells for a Finite Epidermal Niche Promotes Selective Retention of Antigen-specific Memory T Cells in the Epidermis
    Toshiro Hirai · 2022 · YAKUGAKU ZASSHI
15. DIFFERENTIAL SARS-COV-2 ANTIGEN SPECIFICITY OF THE HUMORAL RESPONSE IN INACTIVATED VIRUS-VACCINATED, CONVALESCENT, AND BREAKTHROUGH SUBJECTS
    Luisa Fernanda Duarte, Yaneisi Vázquez, Benjamín Diethelm‐Varela · 2022 · medRxiv
16. Spontaneous Subarachnoid Haemorrhage After COVID-19 Vaccination; a Rare Case Report
    2022
17. Immunology in COVID-19; more than diagnosis of infection or the basis of vaccination
    Natalia Egri, Manel Juan · 2022 · Medicina Clínica (English Edition)
18. COVID-19 vaccination and clinical outcomes of immune checkpoint inhibitors therapy in cancer patients: a meta-analysis of real-world studies
    2026
19. Robust immune responses to SARS-CoV-2 in a pediatric patient with B-Cell ALL receiving tisagenlecleucel
    Oren M. Gordon, Madeline Terpilowski, Robin Yates Dulman, Michael Daniel Keller, Peter D. Burbelo, Jeffrey I. Cohen, Catherine M. Bollard, Hema Dave · 2022 · Pediatric Hematology and Oncology
20. Immunologie in der dermatologischen Praxis – wieviel, warum, wann?
    Evangelia Diamanti, Julia Föhr, Andria Papageorgiou, Matthias Herbst, Sigbert Jahn · 2022 · Aktuelle Dermatologie
21. Peptide immunoarrays for rationale development of vaccines with enhanced cross-reactivity
    Zoë Parker Cates, Antonio Facciuolo, Erin Scruten · 2025 · PLoS ONE
22. Breakthrough Infection After a Primary Series of COVID-19 Vaccination Induces Stronger Humoral Immunity and Equivalent Cellular Immunity to the Spike Protein Compared with Booster Shots
    Yoshifumi Uwamino, Takashi Yokoyama, Yasunori Sato et al. · 2025 · Vaccines
23. Effect of Corticosteroid on Immunogenicity of SARS-CoV-2 Vaccines in Patients With Solid Cancer
    Chayanee Samdaengpan, Prakongboon Sungkasubun, Worawit Chaiwiriyawong et al. · 2024 · JCO Global Oncology
24. A Case of Graves’ Disease Exacerbation Triggered by BNT162b2 Vaccination
    Hideyuki Iwamoto, Tomohiko Kimura, Erina Nakao · 2025 · Cureus
25. Exacerbation of Lupus Erythematosus Panniculitis After Administration of COVID-19 mRNA Vaccine
    2022
26. An immunological autobiography: my year as a COVID-19 vaccine trial participant
    Ross M. Kedl · 2022 · npj Vaccines
27. Differential reactivity of SARS ‐ C o V ‐2 S‐protein T‐cell epitopes in vaccinated versus naturally infected individuals
    Daniel J. Browne, Pauline Crooks, Corey Smith, Denise L. Doolan · 2025 · Clinical & Translational Immunology
28. Repeated-dose toxicity and immunogenicity evaluation of a recombinant subunit COVID-19 vaccine (ZF2001) in rats
    Ruimin Sun, Lijuan Xia, Guangbiao She, Jin-Rong Li, Yi-Ru Wang, Yun-Xiang Chen, Qian Yang, Si-Min Zhang, Fang Liu, Ying Chen et al. · 2025 · Frontiers in Cellular and Infection Microbiology
29. Buckling up against COVID-19 after CAR T-cell therapy
    2022
30. A preliminary study on the effectiveness of maternal to neonatal transfer of antibodies against SARS-CoV-2 in the women vaccinated with heterologous CoronaVac–ChAdOx1
    2023
31. Safety and immunogenicity of PHH-1V booster against SARS-CoV-2 variants, including omicron subvariants: Results from a phase IIb open-label extension study
    María Jesús López Fernández, Maria Del Mar Vazquez, Melchor Álvarez‐Mon, José Ramón Arribas, Eunate Arana‐Arri, Patricia Muñóz, Jorge Navarro-Pérez, Rafel Ramos, José Moltó, Susana Otero‐Romero et al. · 2025 · Human Vaccines & Immunotherapeutics
32. Cutaneous reactions secondary to COVID‐19 vaccination
    2023
33. Acute tubulointerstitial nephritis following a coronavirus disease 2019 vaccine booster dose: a pediatric case report.
    Haruhide Sakaguchi, Daishi Hirano, Y. Takemasa, Y. Hiwatari, S. Yoshizawa, Yosuke Shoji, Aya Saito, Chisato Umeda, Saori Miwa, Akira Ito et al. · 2026 · CEN Case Reports
34. Functional antibody responses to SARS-CoV-2 variants before and after booster vaccination among adults in Ghana
    Frederica Dedo Partey, Abigail Naa Adjorkor Pobee, Isaac Kumi Damptey et al. · 2025 · Experimental Biology and Medicine
35. Active and Passive Immunization of Syrian Hamsters with An Attenuated SARS-CoV-2 Protects against New Variants of Concern
    2022
36. Immunogenicity of the third and fourth BNT162b2 mRNA COVID-19 boosters and factors associated with immune response in systemic lupus erythematosus and rheumatoid arthritis patients
    2022
37. Efficiency enhancement in main path extraction in mRNA vaccine field: A novel approach leveraging intermediate patents, with shielding origin and terminus patent edges
    Ting Zhang, Zhongquan Jian, Juan Chen, Dongzi Xu, Xiaoyi Yang, Yan Lu, Shu Yan, Lizi Pan, Qingqiang Wu, Zhaolian Ouyang · 2025 · Human Vaccines & Immunotherapeutics
38. Quantitative multi-organ proteomics of fatal COVID-19 uncovers tissue-specific effects beyond inflammation
    2022
39. Breakthrough infections by SARS-CoV-2 variants boost cross-reactive hybrid immune responses in mRNA-vaccinated Golden Syrian Hamsters
    J. G. Diego, Gagandeep Singh, S. Jangra, Kim Handrejk, M. Laporte, Lauren A. Chang, S. E. El Zahed, L. Pache, Max W. Chang, Prajakta Warang et al. · 2023 · bioRxiv
40. Side effects of COVID-19 vaccines in paediatric patients: a review systematic and meta-analysis protocol
    Cijara Leonice de Freitas, A. Sarmento, N. Serquiz, Maria Luísa Nobre, A. P. Costa, K. S. Medeiros, A. K. Gonçalves · 2024 · BMJ Open
41. Changing Patterns of SARS-CoV-2 Seroprevalence: A Snapshot among the General Population in Kuwait
    Wadha Ahmed Alfouzan, Haya Altawalah, Ahmad J Al-Sarraf, Walid Q. Alali, Talal Al-Fadalah, Fahad Al-Ghimlas, Saud Alajmi, Mubarak Alajmi, Ebtehal AlRoomi, Ahlam Jeragh et al. · 2023 · Vaccines
42. Hijacking of Cellular Functions by Severe Acute Respiratory Syndrome Coronavirus-2. Permeabilization and Polarization of the Host Lipid Membrane by Viroporins
    2022
43. Complete blood count derived inflammatory biomarkers and the level of anti-SARS-CoV-2 NAb and S-RBD IgG among cancer survivors receiving COVID-19 vaccines
    2023
44. Large‐Scale Screening of CD4+ T‐Cell Epitopes From SARS‐CoV‐2 Proteins and the Universal Detection of SARS‐CoV‐2 Specific T Cells for Northeast Asian Population
    Yu Zhao, Chengtao He, Min Peng, Min Li, Xiaotao Kelvin Liu, Xuelian Han, Qiang Fu, Yandan Wu, Fangping Yue, Chunguang Yan et al. · 2025 · Journal of Medical Virology
45. Unreliable information and fear: Barriers to vaccination among IBD patients in China
    Jingwen Liu, Ze-Lin Yan, Wen Hu, Shuyan Li, Yan Chen · 2025 · Human Vaccines & Immunotherapeutics
46. Vaccine protection and how we measure it
    Bin Ni, Ahmad Yanis, James D. Chappell · 2021 · Transplant Infectious Disease
47. Rapid and potent induction of protective mucosal immunity against SARS-CoV-2 by an adenovirus-vectored nanoparticle vaccine
    Shixiong Li, Qiong Zi, Junhao Fan, Guangzhen Jiang, Yao Zhang, Danni Feng, Zumrat Nur, Xiaoqing Liu, Jintao Lai, Tao Chen et al. · 2026 · Journal of Nanobiotechnology
48. A viral-vectored multipathogen vaccine platform based on replication-competent vaccinia virus and adeno-associated virus
    2026
49. SARS-CoV-2: overview of immune response, insights into vaccine platforms and their challenges
    Balram Ji Omar, Arpana Singh, Vanya Singh, Ashish Kothari, Manju Ohri Pai · 2022 · Exploration of Immunology
50. mRNA COVID-19 vaccines induce enhanced antibody and cellular responses compared to ChAdOx1 or natural infection in children
    2021
51. Increased risk of corneal transplant rejection following SARS-CoV-2 infection and vaccination
    Natalie Elizabeth Allen, Rachael Louise Niederer, Akilesh Gokul · 2026 · International Ophthalmology
52. The Covid-19 Pandemic and the Freedom-Security Tension: Calibrating their Fragile Relationship
    2023
53. Community behavioral change and attitudes on the health protocol during the Covid-19 vaccination period and level 1 restriction (PPKM)
    2023
54. A multiadjuvant polysaccharide-amino acid-lipid (PAL) subunit nanovaccine generates robust systemic and lung-specific mucosal immune responses against SARS-CoV-2 in mice
    Bhawana Pandey, Zhengying Wang, Angela C. Jimenez, Eshant Bhatia, Ritika Jain, Alexander Beach, Drishti Maniar, Justin Hosten, Laura O’Farrell, Casey E. Vantucci et al. · 2023 · bioRxiv (Cold Spring Harbor Laboratory)
55. Spotlight on contributory role of host immunogenetic profiling in SARS-CoV-2 infection: Susceptibility, severity, mortality, and vaccine effectiveness
    Somayeh Yazdanparast, Mehdi Bakhtiyaridovvombaygi, Fatemeh Mikanik, Reza Ahmadi, Mohammad Ghorbani, Mohammad Reza Mansoorian, Mozhgan Mansoorian, Hamid Chegni, Jalil Moshari, Ahmad Gharehbaghian · 2023 · Life Sciences
56. Hybrid and Vaccine-Induced Immunity Against SARS-CoV-2 in a Cohort of Hospitalized Patients from the Metropolitan Aburrá Valley, Colombia
    Olga Hernández, Andrés F. Naranjo, Juan J. Vélez-Cadavid, Gisela De La Rosa, Bladimir Gil, A. Melissa Moreno, Laura S. Perez‐Restrepo, Jaime Úsuga, Manuela Aristizabal-Valencia, Francisco Molina Saldarriaga et al. · 2026 · Vaccines
57. Interdependencies between cellular and humoral immune responses in heterologous and homologous SARS-CoV-2 vaccination
    2021
58. The newly developed porcine-origin parainfluenza virus PIV5-JS17 serves as an exogenous gene delivery system for swine
    2026
59. T-Cell Immunity in COVID-19-Recovered Individuals and Individuals Vaccinated with the Combined Vector Vaccine Gam-COVID-Vac
    С. П. Кречетов, Valentina V. Vtorushina, E. V. Inviyaeva, Elena A. Gorodnova, Колесник Светлана Владимировна, Dmitry Anatolievich Kudlay, Borovikov P.I. Borovikov, Krechetova L.V. Krechetova, Nataliya V. Dolgushina, Gennady Tikhonovich Sukhikh · 2023 · International Journal of Molecular Sciences
60. Vaccines defiance against SARS COV-2 variants at Assiut Governorate
    2024
61. Unraveling the Enzymatic Mechanism of the SARS-CoV-2 RNA-Dependent-RNA-Polymerase. An Unusual Active Site Leading to High Replication Rates
    2022
62. RNA vaccines: A milestone toward a new era
    Srdja Janković · 2023 · Vojnosanitetski pregled
63. Efficacy and safety of inactivated SARS‐CoV‐2 vaccination in COVID‐19‐associated pneumonia among patients with rheumatic and musculoskeletal diseases: A real‐world retrospective observational study
    2024
64. COVID-19 vaccination, implications for PET/CT image interpretation and future perspectives
    2022
65. Longitudinal proteomic investigation of COVID-19 vaccination
    2022
66. Efficacy of Two Vaccine Platforms against SARS-CoV-2
    Ali Ghazavi, Mohsen Khaki, Ghasem Mosayebi, Nafiseh Keshavarzian, Parnian Navabi, Ali Ganji · 2022 · Bulletin de la Banque nationale de Perse.
67. Impact of gender difference towards coronavirus disease 2019 (COVID-19) vaccine antibody response: systematic review
    Mohammad Edwin Prasetyo, Gatot Soegiarto, Laksmi Wulandari · 2023 · Bali Medical Journal
68. Mother’s Pregnancy Trimester Does Not Affect the Differences of IgG SARS-COV-2 Antibody Levels in Pregnant Women after mRNA and Inactivated Coronavirus Disease 2019 Vaccination
    Anita Deborah Anwar, Putri Nadhira Adinda Adriansyah, Ivan Christian Channel, Annisa Dewi Nugrahani, Febriani Febriani, Asep Surachman, Dhanny Primantara Johari Santoso, Akhmad Yogi Pramatirta, Budi Handono · 2023 · Open Access Macedonian Journal of Medical Sciences
69. High temporal resolution systems profiling reveals distinct patterns of interferon response after Covid-19 mRNA vaccination and SARS-CoV2 infection
    Darawan Rinchai, Sara Deola, Gabriele M. Zoppoli, Basirudeen Syed Ahamed Kabeer, Sara Taleb, Igor Pavlovski, Selma Maacha, Giusy Gentilcore, Mohammed Toufiq, Lisa Sara Mathew et al. · 2021 · bioRxiv (Cold Spring Harbor Laboratory)
70. Predictors for cause-specific and timing of deaths in patients with COVID-19: a cohort study in Taiwan
    Yung‐Feng Yen, Shang-Yih Chan, Yun‐Ju Lai · 2024 · BMC Infectious Diseases
71. T Cell Immune Responses against SARS-CoV-2 in the With Corona Era
    Ji-Eun Oh · 2022 · Journal of Experimental & Biomedical Sciences/Biomedical Science Letters
72. Evaluation of anti-spike glycoprotein antibody and neutralizing antibody response of different vaccine platforms. A protocol of systematic review and meta-analysis of COVID-19 vaccine clinical trial studies
    Mohammad Mirzakhani, Safa Tahmasebi, Mohammadreza Dashti, Mohammad Reza Mohammadi, Manizhe Faghih, Mousa Mohammadnia‐Afrouzi, Hadi Esmaeili Gouvarchin Ghaleh, Jafar Amani · 2022 · medRxiv
73. Predictors for COVID-19-Specific and Non-COVID-19-Specific Deaths: A Cohort Study in Taiwan
    Shang-Yih Chan, Hsin-Hao Lai, Yun‐Ju Lai · 2024 · Asia Pacific Journal of Public Health
74. Antibody Response after Second-Dose of Sputnik V, ChAdOxl-nCOV, and BBIBP-CorV in the Iranian General Population
    Ommolbanin Younesian, Mojtaba Pourmomen, Behnaz Khodabakhshi, Shayan Marhamati, Seyedeh Somayeh Hosseini Alarzi, Sara Hosseinzadeh, Samareh Younesian, Mana Zakeri, Hamidreza Joshaghani · 2024 · Molecular Genetics Microbiology and Virology
75. Pre‐Infection COVID‐19 Vaccination and Long‐Term Cardiovascular Outcomes in Adults Without Preexisting Cardiovascular Disease: A Retrospective Cohort Study
    2026
76. Exploring pharmacist role in dispelling myths regarding covid-19 vaccination
    Ayesha Raza Butt, Hafiz Ur Rehman, Musa Bin Bashir, Sandal Khan · 2024 · Asia-Pacific Journal of Pharmacotherapy & Toxicology
77. Preclinical Safety Evaluation of a Replication-Defective Canine Adenovirus Type 2 Vector-Based SARS-CoV-2 Vaccine Candidate in Murine Models
    Denis Omara, Christian Ndekezi, Susan Mugaba, Angella Nakyanzi, Fortunate Natwijuka, Anne A. Kapaata, Frank Kato, Drake Byamukama, David E. Ggwaabya, Orla Mugulusi et al. · 2026 · Vaccines
78. Is there an association between peri-diagnostic vaccination and clinical outcomes in COVID-19 patients?
    2023
79. Comparative Analysis of Nucleocapsid- and Spike-Specific Isotype Humoral Immune Responses Following Natural SARS-CoV-2 Infection and Vaccination with Sinopharm, Sinovac, and AstraZeneca
    Mohamed Hassan Nasraa, Dina Nadeem Abd‐Elshafy, Rola Nadeem, Said Ibrahim Shalaby, Khaled Amer, Wael Ali Hassan, Ahmed Hamdy Bader, Hasnaa A. ElShehaby, Mahmoud Mohamed Bahgat · 2026 · Viral Immunology
80. The Impact of Effective Vaccination on Clinical and Radiological Involvement in COVID-19 Patients
    Coşkun Doğan, Deniz Bilici, Burcu Arpınar Yiğitbaş, Ömer Zengin, Orhan Zor, Oğuzhan Akman, İlyas Kocabağ, Gönül Seven Yalçın, Esra Yazar · 2023 · Medeniyet Medical Journal
81. Unveiling the SARS-CoV-2 Spike Protein: A Comparative Analysis of Vaccine Development Approaches and Glycosylation Implications
    Leonel C Mendoza · 2023 · American Journal of Chemistry and Pharmacy
82. Safety and immunogenicity of the third and fourth doses of vaccine against SARS-CoV-2 following a 2-dose regimen of inactivated whole-virion SARS-CoV-2 vaccine
    Romanee Chaiwarith, Poramed Winichakoon, Parichat Salee, Tavitiya Sudjaritruk, Jiraprapa Wipasa, Kriangkrai Chawansuntati, Saowaluck Yasri, Harit Thongwitokomarn, Kawisara Krasaewes, Sethawut Ruangsirinusorn et al. · 2023 · Scientific Reports
83. Vaccination and vitamin D in relation to disease severity and mortality in patients with COVID-19 disease: a follow-up study.
    2025
84. Evaluation of the Humoral Immune Response Following Two Doses of a Coronavirus Disease 2019 Vector-Based Vaccine During the Initial Rollout in Bangladesh
    Sharmin Sultana, Md. Hossain Rahman, Abu Taher, Md. Nazrul Islam, SM Rashed Ul Islam, Afzalun Nessa · 2025 · Cureus
85. Impaired antibody responses to heterologous ChAdOx1 nCoV-19 and BNT162b2 vaccination in individuals with type 2 diabetes
    2025
86. CHALLENGES IN DEVELOPING VACCINE FOR CANINE DISTEMPER
    2024
87. Distinct immune signatures discriminate SARS-CoV-2 vaccine combinations
    Nicolás Gonzalo Núñez, Jonas Schmid, Laura Power, Chiara Alberti, Sinduya Krishnarajah, Stefanie Kreutmair, Susanne Unger, Sebastián Blanco, Brenda Salomé Konigheim, Constanza Marín et al. · 2022 · medRxiv
88. Effect of maternal COVID-19 vaccination on mandibular molars development in albino rats offspring
    2025
89. Pre-vaccine sentinel antibodies predict blunted vaccine responses
    Lusheng Song, Jin G. Park, Ji Qiu, Vel Murugan, SeyedMasoud Mousavi, Ching‐Wen Hou, D. Mitchell Magee, Zhongxue Chen, Yunro Chung, Stacy Williams et al. · 2026 · Cell Press Blue
90. The Protective Efficacy of a SARS-CoV-2 Vaccine Candidate B.1.351V against Several Variant Challenges in K18-hACE2 Mice
    J.E. Yang, Huifen Fan, Anna Yang, Wenhui Wang, Xin Hua Wan, Fengjie Lin, Dongsheng Yang, Jie Wu, Kaiwen Wang, Wei Li et al. · 2024 · Vaccines
91. Unveiling the Dynamics of the Omicron Variant: Prevalence, Risk Factors, and Vaccination Efficacy during the Third Wave of Covid-19 in Indonesia's Gowa Regency
    2023
92. Long-term antibody waning and antibody-associated protection across diverse SARS-CoV-2 immune histories
    Koki Numakura, Shô Miyamoto, Akiko Sataka, Haruko Takeyama, Tadaki Suzuki · 2026 · Communications Health
93. Gut Microbiota Diversity in Myocardial Infarction Patients Following COVID-19 Vaccination: A Cross-Sectional, Hypothesis-Generating Study
    Firoz Anwar, Fahad Ahmed Al-Abbasi, Abdulkadir Nur, Mohamed Gamil Mehanna, Ryan Adnan Sheikh, Mirza Rafi Baig, Salma Naqvi · 2026 · International Journal of Surgery
94. The Importance of Qualitative/Quantitative Analytical Tools in COVID-19 Vaccine Development
    Behrouz Seyfinejad, Ommoleila Molavi, Abolghasem Jouyban · 2023 · ImmunoAnalysis
95. Cytokine routing as an overlooked determinant of immune mobilization
    2025
96. A bioinformatics approach combined with experimental validation analyzes the efficacy of azithromycin in treating SARS-CoV-2 infection in patients with IPF and COPD
    2025
97. Convalescent Plasma—What is its Perspective in the Treatment of COVID-19 and Other Viral Diseases? A Narrative Review
    2025
98. Immune and biochemical evaluation of a live attenuated lumpy skin disease vaccine in cattle
    2026
99. Seroconversión posterior a la aplicación de vacuna Pfizer anticovid-19 en personal de la salud
    2023
100. Association of Robust Anti-SARS-CoV-2 Trajectories among Communities with and without COVID-19 Infection
     Balamurali Venkatesan, Leela Kakithakara Vajravelu, Sujith Ravi, Jayaprakash Thulukanam, Om Lokesh Muthamilan · 2024 · Journal of Pure and Applied Microbiology